management of Diabetic foot ulcer with homoeopathic therapy

A multicentric open clinical trial To evolve a group of efficacious homoeopathic medicines in the management of Diabetic Foot Ulcer.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/10/002048

Enrollment

100

Registered

2011-10-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients suffering from Diabetic foot ulcer

Interventions

Intervention1: homoeopathic medicines Sulph Sil Lyc Ars. Lach Phos. Sep. Ph ac Op Merc Puls Sec Calc Plb Rhus t : effect of homoeopathiuc medicine on diabetic foot ulcer single dose of in

Eligibility

Inclusion criteria

Inclusion criteria: Both male and female over 30 years of age with diagnosed IDDM or NIDDM, presenting with ulcer on lower extremity for more than 1 week. The patients during the study will be allowed to take allopathic medicaton on which they are dependent. (in consultation with endocrinologist). Gradually the dose will be tapered or withdrawn in consultation with him depending on level of Blood Sugar. If patient is suffering from high fever, antipyretics may be given. In case of severe pain, pain killers can be given,SOS , when homoeopathic medicine fails. (Patient may continue with his anihypertensives, antilipids in consultation with the endocrinologist).

Exclusion criteria

Exclusion criteria: ? Subjects with ill managed diabetes i.e. glycosylated hemoglobin (HbA1c) more than 8%; ? Cases presenting with gangrene or impending gangrene (manifest in sudden black discoloration of skin); ? Ulcers with underlying osteomyelitis; ? Venous ulcers or ulcers due to any other cause; ? Cases presenting with long term complication of diabetes such as severe retinopathy, severe renal involvement or with history of recurrent acute complications like hypoglycemia, ketoacidosis, polyneuropathy etc; ? Patient requiring intravenous antibiotics, emergency management or surgical intervention; ? People suffering from life-threatening or chronic diseases like Ischemic heart disease of less than 6 months duration, or unstable angina, Hypertension, Malignancy, HIV/AIDS etc, and ? H/o diabetic coma.

Design outcomes

Primary

Measure	Time frame
healing of ulcer(decrease in symptom score)Timepoint: healing of ulcer in 6 months	—

Secondary

Measure	Time frame
To establish verified characteristic symptoms of medicines usedTimepoint: To establish verified characteristic symptoms of medicines used in 6 months.	—

Countries

India

Contacts

Public ContactDr Jaya Gupta

central council for research in homoeopathy

jgupta21@gmail.com01128525523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026